Addictions, Drug & Alcohol Institute
Addictions, Drug & Alcohol Institute > ADAI Publications

ADAI Publications

1331 publications found

  1. Kingston S. Overview and Perspectives of Syringe Services Programs in Washington State. Seattle, WA: Addictions, Drug & Alcohol Institute, Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Washington, February 2023
  2. Hartzler B. Is it time to broaden community dissemination of cognitive-behavioral therapy for substance use disorders: Charting pathways to ascend the remaining mountainside [commentary]. Clinical Psychology: Science and Practice 2023;30(2):147-149. [doi: 10.1037/cps0000138]
  3. Peavy KM, Adwell A, Owens MD, Banta-Green CJ. Perspectives on medication treatment for opioid use disorder in adolescents: Results from a provider learning series. Substance Use & Misuse 2023;58(1):160-162. [doi: 10.1080/10826084.2022.2136493] PMID: 36371698
  4. Banta-Green C, Duncan M. Treatment Medications for Fentanyl Use Disorder: Prescriber Practices and Support Needs in WA State. Seattle, WA: Addictions, Drug & Alcohol Institute, Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Washington, September 2023
  5. Fockele CE, Morse SC, van Draanen J, Leyde S, Banta-Green C, Huynh LN, Zatzick A, Whiteside LK. “That line that just kept moving”: Motivations and experiences of people who use methamphetamine. West J Emerg Med 2023;24(2):218-227. [doi: 10.5811/westjem.2022.12.58396] PMID: 36976607 PMCID: PMC10047723
  6. Carlini B, Garrett S, Kellum L, Nims L. Cannabis Research Report, 2021-2023. Seattle, WA: Addictions, Drug & Alcohol Institute, Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Washington, August 2023
  7. Kingston S, Biamont B, Banta-Green C. Community Drug Checking Network. The Use and Impact of Community Drug Checking Services. Seattle, WA: Addictions, Drug & Alcohol Institute, Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Washington, November 2023
  8. Irwin AN, Bratberg J, Al-Jammali Z, Arnold J, Gray M, Floyd AS, Boliver D, Hansen R, Hartun DM, Green TC. Implementation of an academic detailing intervention to increase naloxone distribution and foster engagement in harm reduction from the community clinician. Journal of the American Pharmacists Association 2023;63(1):284-294.e1. [doi: 10.1016/j.japh.2022.12.001] PMID: 36567216 PMCID: PMC9933140
  9. Hall W, Leung J, Carlini BH. Do not let the ideal be the enemy of good enough regulation [commentary]. Addiction 2023;118(6):1009-1010. [doi: 10.1111/add.16201]
  10. Nakata KG, Yin E, Sutlief E, Ferguson SM. Chemogenetic modulation reveals distinct roles of the subthalamic nucleus and its afferents in the regulation of locomotor sensitization to amphetamine in rats. Psychopharmacology 2022;239(2):353-364. [doi: 10.1007/s00213-021-05985-7] PMID: 34549316
  11. Singh S, Banta-Green C, Kingston S. Distribution of Safer Drug Smoking Supplies as a Public Health Strategy. Seattle, WA: Addictions, Drug & Alcohol Institute, Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Washington, January 2022
  12. Firth CL, Carlini B, Dilley J, Guttmanova K, Hajat A. Retail cannabis environment and adolescent use: The role of advertising and retailers near home and school. Health & Place 2022;75:102795. [doi: 10.1016/j.healthplace.2022.102795] PMID: 35344691 PMCID: PMC9189000
  13. Musyoka CM, Mbwayo A, Donovan DM, Mathai M. Student peer mentoring: Feasibility and acceptability of mHealth-based tool for alcohol and substance abuse prevention by peer mentors at a university in Kenya. PLOS Digital Health 2023;2(1):e0000177. [doi: 10.1371/journal.pdig.0000177] PMID: 36812633 PMCID: PMC9931292
  14. Hirchak KA, Lyons AJ, Herron JL, Kordas G, Shaw JL, Jansen K, Avey JP, McPherson SM, Donovan DM, Roll J, Buchwald D, Ries R, McDonell MG, HONOR Study Team. Contingency management for alcohol use disorder reduces cannabis use among American Indian and Alaska Native adults. Journal of Substance Abuse Treatment 2022;137:108693. [doi: 10.1016/j.jsat.2021.108693] PMID: 34952747 PMCID: PMC9086134
  15. Carlini BH, Garrett SB, Nims LN. The kids are not all right: E-cigarettes, cannabis co-use, and an emerging public health crisis: A commentary on Roberts et al. (2022). Journal of Studies on Alcohol and Drugs 2022;83(5):771-772. [doi: 10.15288/jsad.22-00167] PMID: 36136449
  16. Peavy KM, Banta-Green C. Methadone: An Old Medication with Untapped Potential. Seattle, WA: Addictions, Drug & Alcohol Institute, Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Washington, April 2022
  17. Kisicki A, Becker S, Chaple M, Gustafson DH, Hartzler BJ, Jacobson N, Murphy AA, Tapscott S, Molfenter T. Behavioral healthcare organizations’ experiences related to use of telehealth as a result of the COVID-19 pandemic: an exploratory study. BMC Health Services Research 2022;22:775. [doi: 10.1186/s12913-022-08114-y] PMID: 35698186 PMCID: PMC9189799
  18. Carlini BH, Garrett S, Firth C, Pinksy I. Cannabis industry marketing violations in Washington State, 2014-2019. Journal of Studies on Alcohol and Drugs 2022;83:18-26. [doi: 10.15288/jsad.2022.83.18] PMID: 35040756
  19. Merrill JE, Lopez G, Stevens AK, Singh S, Laws MB, Mastroleo N, Magille M, Monti P, Kahler CW. Discussion of alcohol consequences during a brief motivational intervention session: comparing those who do and do not increase readiness to change. Addiction Research & Theory 2022;30(4):279-287. [doi: 10.1080/16066359.2021.2021401] PMID: 37180491 PMCID: PMC10181841
  20. Peavy KM. How to ask if they’re getting addicted. Worried about someone’s drinking or drug use, but not sure what to say? There’s a counselling approach that can help. Psyche (website) 2022; April 8